Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (101-110 of 284) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle OsseuseG Michel, E Gluckman, D Blaise, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancerP Viens, D Blaise, A M Stoppa, et al.
Pathologie-Biologie|September 1, 1988
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients]D Maraninchi, O Hartman, E Benhamou, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
Bone Marrow Transplantation|January 1, 1991
Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patientsL Sutton, V Leblond, C Le Maignan, et al.
Leukemia|July 1, 1994
Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2D Olive, H Chambost, D Sainty, et al.
Bone Marrow Transplantation|October 9, 2007
High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working PartyU De Giorgi, D Blaise, A Lange, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.
Bone Marrow Transplantation|November 1, 1990
Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeadsA M Stoppa, J Hirn, D Blaise, et al.
Pageof 29

Showing results (101-110 of 284) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle OsseuseG Michel, E Gluckman, D Blaise, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancerP Viens, D Blaise, A M Stoppa, et al.
Pathologie-Biologie|September 1, 1988
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients]D Maraninchi, O Hartman, E Benhamou, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
Bone Marrow Transplantation|January 1, 1991
Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patientsL Sutton, V Leblond, C Le Maignan, et al.
Leukemia|July 1, 1994
Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2D Olive, H Chambost, D Sainty, et al.
Bone Marrow Transplantation|October 9, 2007
High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working PartyU De Giorgi, D Blaise, A Lange, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.
Bone Marrow Transplantation|November 1, 1990
Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeadsA M Stoppa, J Hirn, D Blaise, et al.
Pageof 29